Pollock RE - Search Results

1

Exosome-Derived miR-25-3p and miR-92a-3p Stimulate Liposarcoma Progression.

Casadei L, Calore F, Creighton CJ, Guescini M, Batte K, Iwenofu OH, Zewdu A, Braggio DA, Bill KL, Fadda P, Lovat F, Lopez G, Gasparini P, Chen JL, Kladney RD, Leone G, Lev D, Croce CM, Pollock RE. Casadei L, et al. Among authors: pollock re. Cancer Res. 2017 Jul 15;77(14):3846-3856. doi: 10.1158/0008-5472.CAN-16-2984. Epub 2017 Jun 6. Cancer Res. 2017. PMID: 28588009 Free PMC article.

2

Effect of surgery on peripheral blood lymphocyte locomotion through type I collagen.

Gutman H, Risin D, Pollock RE, Pellis NR. Gutman H, et al. Among authors: pollock re. Cancer. 1993 May 1;71(9):2833-7. doi: 10.1002/1097-0142(19930501)71:9<2833::aid-cncr2820710925>3.0.co;2-#. Cancer. 1993. PMID: 8467461

3

The National Cancer Data Base report on soft tissue sarcoma.

Pollock RE, Karnell LH, Menck HR, Winchester DP. Pollock RE, et al. Cancer. 1996 Nov 15;78(10):2247-57. Cancer. 1996. PMID: 8918421

4

Purification and characterization of human lung fibroblast motility-stimulating factor for human soft tissue sarcoma cells: identification as an NH2-terminal fragment of human fibronectin.

Hu M, Pollock RE, Nicolson GL. Hu M, et al. Among authors: pollock re. Cancer Res. 1997 Aug 15;57(16):3577-84. Cancer Res. 1997. PMID: 9270031

5

Telomerase activity of sarcoma cell lines and fibroblasts is independent of p53 status.

Milas M, Yu D, Sun D, Pollock RE. Milas M, et al. Among authors: pollock re. Clin Cancer Res. 1998 Jun;4(6):1573-9. Clin Cancer Res. 1998. PMID: 9626480

6

Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up.

Pearlstone DB, Pisters PW, Bold RJ, Feig BW, Hunt KK, Yasko AW, Patel S, Pollack A, Benjamin RS, Pollock RE. Pearlstone DB, et al. Among authors: pollock re. Cancer. 1999 Jan 1;85(1):85-92. doi: 10.1002/(sici)1097-0142(19990101)85:1<85::aid-cncr12>3.0.co;2-a. Cancer. 1999. PMID: 9921978

7

Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.

Zhang L, Yu D, Hu M, Xiong S, Lang A, Ellis LM, Pollock RE. Zhang L, et al. Among authors: pollock re. Cancer Res. 2000 Jul 1;60(13):3655-61. Cancer Res. 2000. PMID: 10910082

8

Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.

Xiong S, Grijalva R, Zhang L, Nguyen NT, Pisters PW, Pollock RE, Yu D. Xiong S, et al. Among authors: pollock re. Cancer Res. 2001 Feb 15;61(4):1727-32. Cancer Res. 2001. PMID: 11245489

9

Wild type p53 sensitizes soft tissue sarcoma cells to doxorubicin by down-regulating multidrug resistance-1 expression.

Zhan M, Yu D, Lang A, Li L, Pollock RE. Zhan M, et al. Among authors: pollock re. Cancer. 2001 Sep 15;92(6):1556-66. doi: 10.1002/1097-0142(20010915)92:6<1556::aid-cncr1482>3.0.co;2-s. Cancer. 2001. PMID: 11745235

10

Characterization of 11 human sarcoma cell strains: evaluation of cytogenetics, tumorigenicity, metastasis, and production of angiogenic factors.

Hu M, Nicolson GL, Trent JC 2nd, Yu D, Zhang L, Lang A, Killary A, Ellis LM, Bucana CD, Pollock RE. Hu M, et al. Among authors: pollock re. Cancer. 2002 Oct 1;95(7):1569-76. doi: 10.1002/cncr.10879. Cancer. 2002. PMID: 12237927 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

361 results

Search Page

Filters